Embleema Closes $3.7M Series A Funding Round and Joins Techstars Alchemist Blockchain Accelerator Program

  • Series A Round led by strategic investor Pharmagest
  • Welcomes Techstars as an investor and selected into elite Techstars
    Alchemist Blockchain Accelerator in New York

the leader in blockchain for health, announced today that it has closed
a $3.7M Series A funding round, led by strategic partner Pharmagest,
a leading pharmacy software group in Europe, and Techstars.
The funds will serve to accelerate the joint development of
blockchain-based applications for patients and pharmacies, and further
Embleema’s commercial deployment.

In July 2018, Embleema launched PatientTruth in the US, the first
blockchain-based personal health record system, which lets patients
assemble their health history from dispersed health records and gives
them full control over data sharing with smart contracts. Patients
receive tokens in exchange for their active participation in clinical
research. Embleema was the first company to offer practical means for
patients to own their digital health assets, providing both control and
monetization without third party data brokers. Now, it hopes to
accelerate the release of the first decentralized marketplace for
sharing Real World Evidence and Clinical Data.

Joining the 3-month Alchemist
Blockchain Techstars Accelerator
will enable Embleema to gain access
to more than 150 mentors including Internet pioneer Jeff Pulver, Gary
Rubinoff, Managing Partner of Alchemist Capital, a venture fund focused
on blockchain, Trevor Koverko, CEO of Polymath, Leanne Kemp, founder &
CEO of Everledger, or blockchain pioneer Steven Nerayoff, involved in
top projects including Ethereum. The accelerator also provides
investment capital to participating companies.

Techstars, the worldwide network that helps entrepreneurs succeed, and Alchemist,
a global blockchain advisory group, have partnered to bring a new
mentorship-driven accelerator program to New York City: Alchemist
Blockchain Techstars Accelerator. Yossi Hasson of Techstars and Steven
Nerayoff of Alchemist will lead the program along with other mentors and
experts from both companies. The Accelerator will help Embleema founders
gain access to expertise in the nascent – yet rapidly growing –
cryptocurrency and blockchain industry, helping them do more faster.
Selected companies will not only benefit from resources across Techstars
and Alchemist’s ecosystems, but will also have the opportunity to work
closely with leading market players in the blockchain industry.

“We’re excited to welcome Embleema to our newest accelerator program,
and help them succeed by connecting them with leading blockchain
industry players,” said Yossi Hasson, Managing Director at Techstars.
“We believe in the vision of Embleema’s management team and their
ability to set a new benchmark in sharing patient data for research,
ultimately giving every individual more control and participation to
accelerate research and clinical development.”

Robert Chu, CEO and Founder at Embleema added: “Our successful Series A
funding round and integration into Techstars’ Alchemist Blockchain
program will enable us to accelerate the release of the first
decentralized marketplace for health data. Health data owners such as
patients, health networks and research centers will be able to exchange
more relevant and faster data with life sciences companies and
regulators such as the U.S. Food and Drug Administration (FDA) in a
real-time, secure and continuous manner, while ensuring full patient
consent, thus accelerating the release of new treatments for patients.”

About Techstars

Techstars is the worldwide network that helps entrepreneurs succeed.
Techstars founders and their teams connect with other entrepreneurs,
experts, mentors, alumni, investors, community leaders, and corporate
partners who will help their companies grow. Techstars operates three
divisions: Techstars Startup Programs, Techstars Mentorship-Driven
Accelerator Programs and Techstars Corporate Innovation Partnerships.
Techstars Mentorship-Driven Accelerator Programs help founders do more
faster and Techstars Startup Programs inspire, educate and connect
entrepreneurs. Techstars Corporate Innovation Partnerships helps brands
supercharge growth by accelerating innovation and cultural
transformation. Techstars accelerator portfolio includes more than 1,600
companies with a market cap of $18.2 Billion. www.techstars.com

About Embleema

is the patient-driven healthcare blockchain network for secure sharing
of personal health records. Hosted on a private Ethereum blockchain,
Embleema’s consolidated, highly-secure repository provides the
healthcare ecosystem with an undisputed and holistic view of patients’
medical history, Embleema is creating a decentralized healthcare data
economy by connecting the key stakeholders in the healthcare industry,
directly with patients while maintaining the patient’s data sovereignty.

CEO Robert Chu left his role as Senior Vice President, Global Technology
Solutions at IMS Health to found Embleema in June 2017 and is supported
by a team of healthcare and technology executives from Harvard Medical
School, T-Systems, the Pharmaceuticals Division of Pierre Fabre and
iBionext and Nokia / Withings Digital Health.

For more information, please visit www.embleema.com
and follow Embleema on Twitter @Embleema,
, and Facebook.


Alexis Normand
1 781-353-8949

Media (US)
Kimberly Ha
KKH Advisors
1 917-291-5744

Media (Europe)
Jean-François Kitten

error: Content is protected !!